THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM:RPRX) today announces financial results for the first quarter ended March 31, 2008 and provides a clinical development program overview.
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM:RPRX) today announces financial results for the first quarter ended March 31, 2008 and provides a clinical development program overview.